Member Info for Tony2117

Had to have a top up at this price

How’s he ramping a lot on here appreciate his post / which are not ramping just he is spending his time looking into the company and the industry and share it with us / great guy

I personally have been trading for years so do you think I need your advice

I’m very happy with investment here and will buy more as and when I can / go elsewhere and deramp / not long now and we will have it signed off and away we go

Great news

All buys again showing as sells

Sorry Coca Cola / have said there not going to do cannabis drinks my error/ but still lots are

/BNN Bloomberg reported that the Coca-Cola Company is in serious talks with Aurora Cannabis Inc. to develop cannabis drinks which could ease pain, inflammation and cramping./ all drinks company’s will not want to be out of the cannabis market and will have one of the supplies

Then listing on Aim /10p/20p for starters in my opinion

It is the same buildings / but they have removed the vidio link now

iCAN has partnered with Technion university to research ocular therapy: we have a method which allows us to bind cannabinoid compounds to a carrier vehicle which is delivered directly into the eye, much like eye drops; and that enables us to treat a whole range of different diseases.

We have had successful trials for Crohn’s disease, arthritis, multiple sclerosis, epilepsy and irritable bowel syndrome. One thing we have found is that when cannabis is dispensed alongside patients’ other medication, we can see how much less of their prescription medication they need when it is augmented with cannabis. We’ve seen amazing results there, with an average of 25% less prescription drug use in patients who take cannabis.

Peter Redmond, Non-Executive Director

Peter is a corporate financier with over 30 years’ experience in corporate finance and venture capital. He has acted on and assisted a wide range of companies to attain a listing over many years on the Unlisted Securities Market, the Main Market of the London Stock Exchange and AIM, whether by IPO or in many cases via reverse takeovers, across a wide range of sectors, ranging from technology through financial services to natural resources and, in recent years has done so as a director of the companies concerned. He was a founder director of Cleeve Capital plc (now Satellite Solutions Worldwide Group plc) and Mithril Capital plc (now Be Heard Group plc), both listed on AIM, and took a leading role in the reconstruction and refinancing of AIM-quoted 3Legs Resources plc (now SalvaRx). Peter was also primarily responsible for the decision for the Company to invest in both SalvaRx and Eco. He is also a director of Hemogenyx plc (where he was involved in creating the precursor vehicle) and URA Holdings plc.

Director /Following her service as an officer in the Israeli military, Dr Pomeranchik graduated with a BSc and then completed a PhD in plant sciences molecular biology from the Hebrew University of Jerusalem and a multi-disciplinary post-doctorate from the Weizmann Institute, combining structural biology, microbiology and plant science. Inbar has hands-on experience in all aspects of the Biotech industry obtained through 15 years of molecular and genetic research and development: from academic research to commercial project lead, from small start-ups to large corporations. Dr Pomeranchik founded Biodiligence Limited (www.biodiligence.net), a private company, which provides consultancy services in the field of biotechnology and agricultural technology within the Medicinal Cannabis space for venture capitalists, private equity investors and family offices. Inbar also serves on the board of Ananda Developments Plc (www.anandadevelopments.com) as an Executive Director, her role being to provide scientific insight in to potential investments. Inbar also serve as an advisor to Avida Global in Colombia and groups of private high net worth investors in Argentina and Brazil. Inbar is co-founder and Lead Scientist at Montana Optimum Wellness and is at the forefront of the scientific thinking regarding medical cannabis and a well-respected figure in the global cannabis eco-system. She is regular speaker at cannabis conferences around the world, among those conferences you can find her speaking at MJBizCon Las Vegas, CannaTech Tel Aviv, Cannabis Europe, OurCrowd Summit, CannaMexico and many more.

Love this from your link /It is big business. London-based analysts Prohibition Partners estimated that the European cannabis market will be worth £106bn by 2028, while according to the publication Health Europa, the global medical cannabis market was worth $13.4bn (£10bn) in 2018 and is projected to grow to $148bn by 2026.

Malta Cannabis Business Awards 2019 https://montanawellness.co/montana-ceo-wins-cannabiz-malta-cannabis-business-awards-2019/ can’t ask for a better director and in my opinion she cares about the average investors

Very interesting thanks for sharing

One week closer to the gov to give the go ahead / which in my own personal opinion is 100% done deal then we we see this baby go / have a good weekend all

Sell lol

Most are buys today my top up showing as a sale / you are trying so hard to be negative but not very good at it

One post wonder/ please explain?